Aigen Investment Management’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CCM
GCM
RIM
KCM
Aigen Investment Management's LMAT Position: Q2 2021 in Review
Aigen Investment Management sold out of LeMaitre Vascular (LMAT) in Q2 2021, closing a stake of 4,838 shares — an estimated $236K sold.
Aigen Investment Management first reported a position in LMAT in Q4 2019 and held it in 4 quarters. The position peaked at $329K in Q2 2020. 185 funds tracked by Wall St. Rank hold LMAT as of Q2 2021.
- Aigen Investment Management reported no remaining LeMaitre Vascular position as of Q2 2021 after selling out during the quarter.
- Aigen Investment Management sold 4,838 LeMaitre Vascular shares in Q2 2021, an estimated $236K.
- Aigen Investment Management first reported a position in LeMaitre Vascular in Q4 2019 and held it in 4 quarters.
- Aigen Investment Management's LeMaitre Vascular position peaked at $329K in Q2 2020.
- 185 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2021.
Based on Aigen Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.